Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Efficacy and safety of olanzapine/fluoxetine combination vs fluoxetine monotherapy following successful combination therapy of treatment-resistant major depressive disorder.

Brunner E, Tohen M, Osuntokun O, Landry J, Thase ME.

Neuropsychopharmacology. 2014 Oct;39(11):2549-59. doi: 10.1038/npp.2014.101. Epub 2014 May 7.

2.

An integrated analysis of olanzapine/fluoxetine combination in clinical trials of treatment-resistant depression.

Trivedi MH, Thase ME, Osuntokun O, Henley DB, Case M, Watson SB, Campbell GM, Corya SA.

J Clin Psychiatry. 2009 Mar;70(3):387-96. Epub 2009 Mar 10.

PMID:
19284928
3.

A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, fluoxetine, and venlafaxine in treatment-resistant depression.

Corya SA, Williamson D, Sanger TM, Briggs SD, Case M, Tollefson G.

Depress Anxiety. 2006;23(6):364-72.

PMID:
16710853
4.

A 7-week, randomized, double-blind trial of olanzapine/fluoxetine combination versus lamotrigine in the treatment of bipolar I depression.

Brown EB, McElroy SL, Keck PE Jr, Deldar A, Adams DH, Tohen M, Williamson DJ.

J Clin Psychiatry. 2006 Jul;67(7):1025-33.

PMID:
16889444
5.

Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.

Benazzi F, Berk M, Frye MA, Wang W, Barraco A, Tohen M.

J Clin Psychiatry. 2009 Oct;70(10):1424-31. doi: 10.4088/JCP.08m04772gre.

PMID:
19906346
6.

Effectiveness and safety of the combination of fluoxetine and olanzapine in outpatients with bipolar depression: an open-label, randomized, flexible-dose study in Puerto Rico.

Tamayo JM, Sutton VK, Mattei MA, Diaz B, Jamal HH, Vieta E, Zarate CA Jr, Fumero I, Tohen M.

J Clin Psychopharmacol. 2009 Aug;29(4):358-61. doi: 10.1097/JCP.0b013e3181ad223f.

7.
8.

Olanzapine/Fluoxetine combination in children and adolescents with bipolar I depression: a randomized, double-blind, placebo-controlled trial.

Detke HC, DelBello MP, Landry J, Usher RW.

J Am Acad Child Adolesc Psychiatry. 2015 Mar;54(3):217-24. doi: 10.1016/j.jaac.2014.12.012. Epub 2014 Dec 29.

9.

A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, and fluoxetine in treatment-resistant major depressive disorder.

Thase ME, Corya SA, Osuntokun O, Case M, Henley DB, Sanger TM, Watson SB, Dubé S.

J Clin Psychiatry. 2007 Feb;68(2):224-36.

PMID:
17335320
10.

Efficacy, safety and tolerability of Symbyax for acute-phase management of treatment-resistant depression.

Bobo WV, Shelton RC.

Expert Rev Neurother. 2010 May;10(5):651-70. doi: 10.1586/ern.10.44. Review.

PMID:
20420487
11.
12.

Olanzapine/fluoxetine combination vs. lamotrigine in the 6-month treatment of bipolar I depression.

Brown E, Dunner DL, McElroy SL, Keck PE, Adams DH, Degenhardt E, Tohen M, Houston JP.

Int J Neuropsychopharmacol. 2009 Jul;12(6):773-82. doi: 10.1017/S1461145708009735. Epub 2008 Dec 11.

PMID:
19079815
13.

The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study.

Marcus RN, McQuade RD, Carson WH, Hennicken D, Fava M, Simon JS, Trivedi MH, Thase ME, Berman RM.

J Clin Psychopharmacol. 2008 Apr;28(2):156-65. doi: 10.1097/JCP.0b013e31816774f9.

PMID:
18344725
14.

Olanzapine/fluoxetine combination for treatment-resistant depression: a controlled study of SSRI and nortriptyline resistance.

Shelton RC, Williamson DJ, Corya SA, Sanger TM, Van Campen LE, Case M, Briggs SD, Tollefson GD.

J Clin Psychiatry. 2005 Oct;66(10):1289-97.

PMID:
16259543
15.

A 24-week open-label extension study of olanzapine-fluoxetine combination and olanzapine monotherapy in the treatment of bipolar depression.

Corya SA, Perlis RH, Keck PE Jr, Lin DY, Case MG, Williamson DJ, Tohen MF.

J Clin Psychiatry. 2006 May;67(5):798-806.

PMID:
16841630
16.

Association of common variations in the norepinephrine transporter gene with response to olanzapine-fluoxetine combination versus continued-fluoxetine treatment in patients with treatment-resistant depression: a candidate gene analysis.

Houston JP, Lau K, Aris V, Liu W, Fijal BA, Heinloth AN, Perlis RH.

J Clin Psychiatry. 2012 Jun;73(6):878-85. doi: 10.4088/JCP.10m06744. Epub 2012 Mar 6.

PMID:
22480387
17.

Analyses of treatment-emergent mania with olanzapine/fluoxetine combination in the treatment of bipolar depression.

Keck PE Jr, Corya SA, Altshuler LL, Ketter TA, McElroy SL, Case M, Briggs SD, Tohen M.

J Clin Psychiatry. 2005 May;66(5):611-6.

PMID:
15889948
18.

A double-blind, randomized study of olanzapine and olanzapine/fluoxetine combination for major depression with psychotic features.

Rothschild AJ, Williamson DJ, Tohen MF, Schatzberg A, Andersen SW, Van Campen LE, Sanger TM, Tollefson GD.

J Clin Psychopharmacol. 2004 Aug;24(4):365-73.

PMID:
15232326
19.

Drug safety evaluation of olanzapine/fluoxetine combination.

Cristancho MA, Thase ME.

Expert Opin Drug Saf. 2014 Aug;13(8):1133-41. doi: 10.1517/14740338.2014.933804. Epub 2014 Jun 27. Review.

PMID:
24972823
20.

Effects of olanzapine-fluoxetine combination treatment of major depressive disorders on the quality of life during acute treatment period.

Qu W, Gu S, Luo H, Tang Q, Guo J.

Cell Biochem Biophys. 2014 Dec;70(3):1799-802. doi: 10.1007/s12013-014-0131-1.

PMID:
25062968

Supplemental Content

Support Center